CAD 0.04
(0.0%)
Year | Net Debt | Net Debt Growth |
---|---|---|
2023 | 4.08 Million CAD | -46.76% |
2022 | 7.67 Million CAD | 1.07% |
2021 | 7.58 Million CAD | 28.79% |
2020 | 5.89 Million CAD | 275.95% |
2019 | 1.56 Million CAD | 548.69% |
2018 | -349.35 Thousand CAD | 25.65% |
2017 | -469.89 Thousand CAD | -213.26% |
2016 | -150 Thousand CAD | 0.0% |
Year | Net Debt | Net Debt Growth |
---|---|---|
2024 Q1 | 3.91 Million CAD | -4.02% |
2024 Q3 | 5.75 Million CAD | 12.35% |
2024 Q2 | 4.68 Million CAD | 19.62% |
2023 Q2 | 3.73 Million CAD | -34.22% |
2023 Q1 | 5.67 Million CAD | -25.99% |
2023 FY | 4.08 Million CAD | -46.76% |
2023 Q4 | 4.08 Million CAD | -2.37% |
2023 Q3 | 4.18 Million CAD | 12.01% |
2022 Q4 | 7.67 Million CAD | -5.29% |
2022 Q1 | 8.27 Million CAD | 9.08% |
2022 Q3 | 8.09 Million CAD | 0.38% |
2022 FY | 7.67 Million CAD | 1.07% |
2022 Q2 | 8.06 Million CAD | -2.54% |
2021 Q3 | 6.57 Million CAD | 1.57% |
2021 Q2 | 6.47 Million CAD | 9.43% |
2021 Q1 | 5.91 Million CAD | 0.42% |
2021 Q4 | 7.58 Million CAD | 15.39% |
2021 FY | 7.58 Million CAD | 28.79% |
2020 Q1 | 5.37 Million CAD | 242.87% |
2020 FY | 5.89 Million CAD | 275.95% |
2020 Q4 | 5.89 Million CAD | 8.76% |
2020 Q3 | 5.41 Million CAD | -11.57% |
2020 Q2 | 6.12 Million CAD | 14.01% |
2019 Q1 | -400.87 Thousand CAD | 3.89% |
2019 Q3 | -957.31 Thousand CAD | 73.37% |
2019 Q4 | 1.56 Million CAD | 263.74% |
2019 FY | 1.56 Million CAD | 548.69% |
2019 Q2 | -3.59 Million CAD | -796.66% |
2018 Q4 | -417.08 Thousand CAD | 3.13% |
2018 FY | -349.35 Thousand CAD | 25.65% |
2018 Q3 | -430.56 Thousand CAD | 8.37% |
2018 Q2 | -469.89 Thousand CAD | 1.61% |
2018 Q1 | -477.57 Thousand CAD | 2.22% |
2017 Q4 | -488.43 Thousand CAD | 2.43% |
2017 Q3 | -500.57 Thousand CAD | 0.0% |
2017 FY | -469.89 Thousand CAD | -213.26% |
2016 FY | -150 Thousand CAD | 0.0% |
Name | Net Debt | Net Debt Difference |
---|---|---|
Aequus Pharmaceuticals Inc. | 4.89 Million CAD | 16.541% |
Decibel Cannabis Company Inc. | 37.48 Million CAD | 89.104% |
Delivra Health Brands Inc. | -2.17 Million CAD | 287.948% |
Entourage Health Corp. | 150.32 Million CAD | 97.283% |
Lifeist Wellness Inc. | -188.12 Thousand CAD | 2270.911% |
Cannara Biotech Inc. | 41.51 Million CAD | 90.162% |
Medicure Inc. | -5.82 Million CAD | 170.114% |
PharmaCielo Ltd. | 18.24 Million CAD | 77.617% |
Rubicon Organics Inc. | 475.37 Thousand CAD | -759.141% |
BioSyent Inc. | -3.68 Million CAD | 210.832% |
Voyageur Pharmaceuticals Ltd. | 37.91 Thousand CAD | -10671.763% |